Investigating permeability related hurdles in oral delivery of 11-keto-β-boswellic acid

International Journal of Pharmaceutics

Volumn 464, Issue 1-2, 2014, Pages 104-110

  Bagul, Pravin ^a   Khomane, Kailas S ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Boswellic acids; Caco 2 cells; Gastrointestinal metabolism; Intestinal absorption; Oral bioavailability; Permeability hurdles

Indexed keywords

11 OXO BETA BOSWELLIC ACID; COLECALCIFEROL; CYTOCHROME P450 3A4;

ACTIVE TRANSPORT; ADSORPTION KINETICS; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DESORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG PENETRATION; DRUG STABILITY; INTESTINE CELL; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT;

BOSWELLIC ACIDS; CACO-2 CELLS; GASTROINTESTINAL METABOLISM; INTESTINAL ABSORPTION; ORAL BIOAVAILABILITY; PERMEABILITY HURDLES;

ADMINISTRATION, ORAL; ANIMALS; CACO-2 CELLS; DRUG DELIVERY SYSTEMS; HUMANS; INTESTINAL ABSORPTION; MALE; PERMEABILITY; RATS, SPRAGUE-DAWLEY; TRITERPENES;

EID: 84896733622     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.01.019     Document Type: Article

References (30)

1. H. Ammon Salai Guggal - Boswellia serrata: from a herbal medicine to a specific inhibitor of leukotriene biosynthesis Phytomedicine 3 1996 67 70
2. H. Ammon, T. Mack, G. Singh, and H. Safayhi Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata Planta Med. 57 1991 203 207
3. P. Artursson, and J. Karlsson Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem. Biophys. Res. Commun. 175 1991 880 885
4. L. Barthe, J. Woodley, S. Kenworthy, and G. Houin An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine Eur. J. Drug Metab. Pharmacokinet. 23 1998 313 323 (Pubitemid 28401125)
5. G. Culioli, C. Mathe, P. Archier, and C. Vieillescazes A lupane triterpene from frankincense Phytochemistry 62 2003 537 541
6. FDA Guidance for Industry Waiver of In-vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System 2000 Center for Drug Evaluation and Research Rockville
7. L. Fossati, R. Dechaume, E. Hardillier, D. Chevillon, C. Prevost, S. Bolze, and N. Maubon Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs Int. J. Pharm. 360 2008 148 155
8. K. Gerbeth, J. Hüsch, G. Fricker, O. Werz, M. Schubert-Zsilavecz, and M. Abdel-Tawab In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins Fitoterapia 84 2013 99 106
9. I. Gupta, V. Gupta, A. Parihar, S. Gupta, R. Lüdtke, H. Safayhi, and H. Ammon Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study Eur. J. Med. Res. 3 1998 511
10. I.J. Hidalgo, T.J. Raub, and R.T. Borchardt Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 1989 736 749 (Pubitemid 19057595)
11. 3 treated Caco-2 cells Int. J. Pharm. 337 2007 169 177 (Pubitemid 46756042)
12. F. Ingels, S. Deferme, E. Destexhe, M. Oth, G. Van den Mooter, and P. Augustijns Simulated intestinal fluid as transport medium in the Caco-2 cell culture model Int. J. Pharm. 232 2002 183 192 (Pubitemid 34076764)
13. K.S. Khomane, P.P. Nandekar, B. Wahlang, P. Bagul, N. Shaikh, Y.B. Pawar, C.L. Meena, A.T. Sangamwar, R. Jain, and K. Tikoo Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647 Mol. Pharm. 9 2012 2458 2468
14. G. Krishna, K.-J. Chen, C.-C. Lin, and A.A. Nomeir Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2 Int. J. Pharm. 222 2001 77 89 (Pubitemid 32525789)
15. P. Krüger, J. Kanzer, J. Hummel, G. Fricker, M. Schubert-Zsilavecz, and M. Abdel-Tawab Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2 Eur. J. Pharm. Sci. 36 2009 275 284
16. M.A. Tawab, A. Kaunzinger, U. Bahr, M. Karas, M. Wurglics, and M. Schubert-Zsilavecz Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasma J. Chromatogr. B: Biomed. Appl. 761 2001 221 227 (Pubitemid 32817112)
17. D. Poeckel, and O. Werz Boswellic acids: biological actions and molecular targets Curr. Med. Chem. 13 2006 3359 3369 (Pubitemid 44873750)
18. H. Safayhi, T. Mack, J. Sabieraj, M.I. Anazodo, L.R. Subramanian, and H. Ammon Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase J. Pharmacol. Exp. Ther. 261 1992 1143 1146
19. E.R. Sailer, L.R. Subramanian, B. Rall, R.F. Hoernlein, H.P. Ammon, and H. Safayhi Acetyl-11-keto - boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity Br. J. Pharmacol. 117 1996 615 618 (Pubitemid 26070238)
20. P. Schmiedlin-Ren, K.E. Thummel, J.M. Fisher, M.F. Paine, K.S. Lown, and P.B. Watkins Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α, 25-dihydroxyvitamin D3 Mol. Pharmacol. 51 1997 741 754 (Pubitemid 27224679)
21. M. Sharma, S. Bani, and G. Singh Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis Int. J. Immunopharmacol. 11 1989 647 652 (Pubitemid 19239439)
22. M. Sharma, A. Khajuria, A. Kaul, S. Singh, G. Singh, and C. Atal Effect of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leucocyte migration Agents Actions 24 1988 161 164
23. S. Sharma, V. Thawani, L. Hingorani, M. Shrivastava, V.R. Bhate, and R. Khiyani Pharmacokinetic study of 11-keto [beta]-boswellic acid Phytomedicine 11 2004 255 260 (Pubitemid 38314069)
24. A.-K. Sohlenius-Sternbeck, and A. Orzechowski Characterization of the rates of testosterone metabolism to various products and of glutathione transferase and sulfotransferase activities in rat intestine and comparison to the corresponding hepatic and renal drug-metabolizing enzymes Chem. Biol. Interact. 148 2004 49 56 (Pubitemid 38824660)
25. E.G. van de Kerkhof, I.A. de Graaf, M.H. de Jager, and G.M. Groothuis Induction of phase I and II drug metabolism in rat small intestine and colon in vitro Drug Metab. Dispos. 35 2007 898 907 (Pubitemid 46798600)
26. B. Wahlang, Y.B. Pawar, and A.K. Bansal Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model Eur. J. Pharm. Biopharm. 77 2011 275 282
27. T.H. Wilson, and G. Wiseman The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface J. Physiol. 123 1954 116 125
28. M. Winking, S. Sarikaya, A. Rahmanian, A. Jödicke, and D.-K. Böker Boswellic acids inhibit glioma growth: a new treatment option? J. Neurooncol. 46 2000 97 103 (Pubitemid 30352616)
29. S. Yee In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth Pharm. Res. 14 1997 763 766 (Pubitemid 27281671)
30. Y. Zhang, C. Bachmeier, and D.W. Miller In vitro and in vivo models for assessing drug efflux transporter activity Adv. Drug Deliv. Rev. 55 2003 31 51 (Pubitemid 36078453)